Scope of Services
Define mentorship, lab/facility access, introductions, clinical trial support, and any paid services with measurable milestones and deliverables to avoid scope creep during the cohort.
A well-drafted Healthcare Accelerator Agreement reduces ambiguity about services, timelines, IP ownership, and data handling, and helps protect patient data and regulatory compliance. It aligns expectations between program operators, startups, and potential investors, limiting disputes and improving probability of successful product development and commercialization.
Accelerator organizations, startup founders, legal counsel, and clinical partners commonly use this agreement to formalize program participation and responsibilities.
The agreement is also reviewed by corporate counsel and compliance officers to confirm HIPAA, research, and commercialization provisions are adequate.
The program director signs for the accelerator and is responsible for delivering stated services, enforcing milestones, and allocating resources. Their signature binds the operator to confidentiality, indemnity, and program schedule obligations.
The startup CEO or authorized officer signs on behalf of the participant entity, accepting equity or fee terms, IP assignment or license clauses, data sharing provisions, and representations about regulatory compliance.
Define mentorship, lab/facility access, introductions, clinical trial support, and any paid services with measurable milestones and deliverables to avoid scope creep during the cohort.
Specify cash fees, milestone payments, convertible notes, or equity stakes, including valuation mechanics, dilution protections, and vesting schedules tied to program milestones.
State ownership or license of pre-existing IP, assignment of newly created IP, licensing terms for platform technologies, and mechanisms for inventor credit and patent prosecution costs.
Include HIPAA-compliant data-handling obligations, BAA requirements where PHI may be exchanged, encryption and access controls, and breach notification timelines.
Describe any commitments to regulatory strategy, assistance with FDA submissions, shared responsibilities for clinical data, and disclaimers about regulatory outcomes.
Detail termination rights for cause or convenience, post-termination obligations for data and IP, survivability of confidentiality clauses, and dispute resolution methods.
| Field | Configuration |
|---|---|
| Authentication Method | Use email plus optional SMS OTP or KBA for higher assurance. |
| Signer Order | Define sequential or parallel signing order per party role. |
| Required Attachments | Require IDs or supporting exhibits at signing where needed. |
| Retention Settings | Enable immutable audit trail and export to secure storage. |
Date by which startups must submit applications and materials.
First official cohort day and commencement of services.
Specific delivery or demo dates tied to funding or resources.
Date when assignment or license obligations begin.
Annual check to confirm storage and deletion schedules.
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | 7-day free trial, no credit card | Varies by vendor | Varies by vendor | Varies by vendor | Varies by vendor |
| Bulk Send | Available (Business Premium) | Available | Available | Available | Not available on basic plans |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| HIPAA Compliant | Yes (BAA required) | Yes | Yes | No | No |
Optica used a standardized cohort agreement to clarify IP licensing and demo day obligations.
Fertility Centers included a tailored BAA for clinical data sharing.